Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation

Volume: 50, Issue: 3, Pages: 639 - 653
Published: Sep 1, 2021
Abstract
Irritable bowel syndrome with constipation is a common disorder that significantly impairs quality of life. There are now multiple classes of therapeutics that have been shown via rigorous clinical testing to improve the abdominal and bowel symptoms attributed to irritable bowel syndrome with constipation. These include the secretagogues (lubiprostone, linaclotide, plecanatide, tenapenor) and the prokinetic agent tegaserod. This article...
Paper Details
Title
Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation
Published Date
Sep 1, 2021
Volume
50
Issue
3
Pages
639 - 653
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.